CNS Pharmaceuticals, Inc.
Recent Filings
All 368 filings →Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Gumulka Jerzy | — | Purchase | 33,333 @ $0.30 | 43,006 | Feb 1, 2024 |
| Evans Carl Anthony | — | Purchase | 33,333 @ $0.30 | 33,458 | Feb 1, 2024 |
| Downs Christopher | Chief Financial Officer | Purchase | 66,666 @ $0.30 | 103,438 | Feb 1, 2024 |
| Climaco John M | Chief Executive Officer | Purchase | 166,666 @ $0.30 | 215,676 | Feb 1, 2024 |
| Downs Christopher | Chief Financial Officer | Purchase | 27,000 @ $1.27 | 36,772 | Aug 22, 2023 |
| Climaco John M | Chief Executive Officer | Purchase | 2,750 @ $1.80 | 49,010 | Aug 16, 2023 |
| Gumulka Jerzy | — | Purchase | 2,500 @ $1.70 | 9,673 | Apr 19, 2023 |
| Downs Christopher | Chief Financial Officer | Purchase | 3,100 @ $3.20 | 9,251 | Apr 17, 2023 |
| Climaco John M | Chief Executive Officer | Purchase | 15,000 @ $0.69 | 45,010 | Apr 12, 2023 |
| Gumulka Jerzy | — | Purchase | 7,173 @ $0.74 | 7,173 | Apr 10, 2023 |